• Case-Based Roundtable
  • General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis
  • Buy-and-Bill

News

Article

Gearing Up for Fall Clinical 2024 With Raj Chovatiya, MD, PhD

Key Takeaways

  • The conference will highlight late-breaking therapeutic updates, innovative treatments, and contemporary disease states, with a focus on chronic hand eczema and early career controversies.
  • Dr. Raj Chovatiya anticipates an exponential increase in new mechanisms of action and innovative uses for existing treatments, particularly in psoriasis and atopic dermatitis.
SHOW MORE

The conference will feature presentations on a number of disease states, therapeutic options, and new clinical data.

Ahead of the 44th Annual Fall Clinical Dermatology Conference in Las Vegas, Nevada, Dermatology Times sat down with Raj Chovatiya, MD, PhD, MSCI, clinical associate professor at the Rosalind Franklin University Chicago Medical School in Illinois, founder and director of the Center for Medical Dermatology and Immunology Research, and Dermatology Times' Fall Editor in Chief, to ask what he is most looking forward to this year. Chovatiya, like many others attending the conference, talked about his excitement for late-breaking therapeutic updates, innovative treatments, and contemporary disease states.

During the 4-day meeting, attendees will listen in on dozens of sessions hosted by key leaders in the dermatology community, including Chovatiya himself, who will host presentations titled, “Chronic Hand Eczema: Pathophysiology, Diagnosis, and Disease Management” and “Early Career Controversies”. A wide range of topics, including new late-breaking data and posters, will be presented during the event.

Dermatology Times editors will be on-site providing live coverage, including expert interviews, session recaps, late-breaking research rundowns, and more.

TRANSCRIPT

Chovatiya: Hi there. My name is Dr Raj Chovatiya. I'm a clinical associate professor at the Rosalind Franklin University Chicago Medical School, and founder and director of the Center for Medical Dermatology and Immunology Research, and one of the quarterly editors in chief for Dermatology Times. I'm really excited to be going to Fall Clinical this year more so than years in the past. I know what you're thinking, you probably hear the same thing every year. But this year we have even more late-breaking therapeutic updates than ever before. It seems like year after year there's an exponential increase in not only new mechanisms of action that I'm really excited to hear about, but also new, innovative and practical ways to maybe use some of our old favorites as well.

Whether your disease state is something like psoriasis, which has been around for a while but still has a lot going on, or something like atopic dermatitis, which, if you'd heard me talk about on the Dermatology Times channels for a few years now, we have a lot of new stuff happening, both in the systemic and non-systemic realm. A newer disease state I'm particularly invested in, not only because I'm talking about it, but others are too, is chronic hand eczema. This is a disease that has really gained a lot of traction, in part because there's a lot of really innovative thinking going on in terms of how we can get around thinking about treatment for this disease. Bottom line, there's a little bit of something for everyone, and I'm really excited to take part.

[This transcript has been edited for clarity.]

Don't miss a moment of our coverage by turning on social media notifications and subscribing to receive updates via email here.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.